COLL COLLEGIUM PHARMACEUTICAL INC Other Situations 8-K Filing 2023 - Press Release and Share Repurchase Program Announcement Collegium Pharmaceutical, Inc. issued a press release announcing full-year revenue, adjusted operating expense and adjusted EBITDA guidance for 2023, as well as a new share repurchase program for 2023.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC